Dynavax (DVAX) Rockets 38% on Sanofi $2-Billion Merger

0
184

We recently published 10 Stocks Lighting Up Market Ahead of Christmas. Dynavax Technologies Corp. (NASDAQ:DVAX) is one of the best performers on Wednesday.

Dynavax soared by 38.19 percent on Wednesday to close at $15.38 apiece as investors took heart from news that it was set to be acquired by Sanofi for $2.2 billion.

In a statement, Dynavax Technologies Corp. (NASDAQ:DVAX) said that it officially entered into an agreement with Sanofi for the latter’s acquisition of all its outstanding shares at a price of $15.50 apiece.

The offer price represents a premium of approximately 39 percent over its closing price on December 23.

The acquisition would augment Sanofi’s presence in adult immunization, particularly with Dynavax Technologies Corp.’s (NASDAQ:DVAX) adult hepatitis B vaccine Heplisav-B—currently marketed in the US and differentiated by its two-dose regimen…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here